Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Prostate Cancer

  Free Subscription


1 AJR Am J Roentgenol
1 Am J Clin Oncol
1 BJU Int
1 BMC Cancer
2 BMC Urol
1 Br J Cancer
4 Cancer
1 Cancer Lett
1 Discov Oncol
1 Eur Urol
2 Int J Radiat Oncol Biol Phys
3 Int J Urol
2 J Magn Reson Imaging
1 J Natl Cancer Inst
1 J Nucl Med
1 J Urol
1 Nat Rev Urol
1 PLoS Med
2 PLoS One
1 Ther Adv Urol
1 Urology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
    PI-RADS Upgrading Rules: Impact on Prostate Cancer Detection and Biopsy Avoidance of MRI-Directed Diagnostic Pathways.
    AJR Am J Roentgenol. 2024 Feb 14. doi: 10.2214/AJR.23.30611.
    PubMed         Abstract available

    Am J Clin Oncol

  2. CHAKRANI Z, Mellgard G, Saffran N, McCroskery S, et al
    Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted Therapy.
    Am J Clin Oncol. 2024 Feb 12. doi: 10.1097/COC.0000000000001087.
    PubMed         Abstract available

    BJU Int

  3. ZUUR LG, de Barros HA, van Oosterom MN, Berrens AC, et al
    (99m) TcPSMA-radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE-II trial.
    BJU Int. 2024 Feb 12. doi: 10.1111/bju.16297.
    PubMed         Abstract available

    BMC Cancer

  4. FARAMARZI S, Kiani B, Faramarzi S, Firouraghi N, et al
    Cancer patterns in Iran: a gender-specific spatial modelling of cancer incidence during 2014-2017.
    BMC Cancer. 2024;24:191.
    PubMed         Abstract available

    BMC Urol

  5. WANG C, Du J, Xiang X, Wang Y, et al
    46, XX disorder of sexual development associated with mixed germ cell tumor of the prostate: a rare case report.
    BMC Urol. 2024;24:36.
    PubMed         Abstract available

  6. SAYAN M, Langoe A, Aynaci O, Eren AA, et al
    Prostate cancer presentation and management in the Middle East.
    BMC Urol. 2024;24:35.
    PubMed         Abstract available

    Br J Cancer

  7. CONSTANTIN TA, Varela-Carver A, Greenland KK, de Almeida GS, et al
    Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer.
    Br J Cancer. 2024 Feb 14. doi: 10.1038/s41416-024-02606.


  8. WRIGHT JL, Schenk JM, Gulati R, Beatty SJ, et al
    The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance.
    Cancer. 2024 Feb 14. doi: 10.1002/cncr.35241.
    PubMed         Abstract available

  9. LOEB S, Hua Q, Bauer SR, Kenfield SA, et al
    Plant-based diet associated with better quality of life in prostate cancer survivors.
    Cancer. 2024 Feb 13. doi: 10.1002/cncr.35172.
    PubMed         Abstract available

  10. HIGANO CS, Dizdarevic S, Logue J, Richardson T, et al
    Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (REASSURE).
    Cancer. 2024 Feb 10. doi: 10.1002/cncr.35221.
    PubMed         Abstract available

  11. DORFF TB, Bryce AH
    Challenges in clinical trials for high-risk but curable prostate cancer.
    Cancer. 2024 Feb 10. doi: 10.1002/cncr.35245.

    Cancer Lett

  12. ZHAO G, Forn-Cuni G, Scheers M, Lindenbergh PP, et al
    Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer.
    Cancer Lett. 2024 Feb 7:216657. doi: 10.1016/j.canlet.2024.216657.
    PubMed         Abstract available

    Discov Oncol

  13. HUANG S, Wu L, Lin S, Cai S, et al
    Analysis of factors related to osteoporotic vertebral fracture in prostate cancer patients.
    Discov Oncol. 2024;15:34.
    PubMed         Abstract available

    Eur Urol

  14. FALKENBACH F, Sanguedolce F, Budaus L
    Re: Elie Kaplan-Marans, Tenny R. Zhang, Jim C. Hu. Differing Recommendations on Prostate Biopsy Approach to Minimize Infections: An Examination of the European Association of Urology and American Urological Association Guidelines. Eur Urol. 2023;84:44
    Eur Urol. 2023;84:e149-e150.

    Int J Radiat Oncol Biol Phys

  15. WESTLEY RL, Biscombe K, Dunlop A, Mitchell A, et al
    Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:682-687.
    PubMed         Abstract available

  16. STAAL FHE, Janssen J, Oprea-Lager DE, Engelen AM, et al
    Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Based Clinical Target Volume Delineation Guideline for Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline.
    Int J Radiat Oncol Biol Phys. 2024;118:688-696.
    PubMed         Abstract available

    Int J Urol

  17. PARK SJ, Park YJ, Park SM
    Response to comment: Revisiting the impact of antibiotics on prostate cancer risk: Beyond the gut microbiota.
    Int J Urol. 2024 Feb 15. doi: 10.1111/iju.15431.

  18. OBINATA D, Takayama K, Inoue S, Takahashi S, et al
    Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries.
    Int J Urol. 2024 Feb 12. doi: 10.1111/iju.15424.
    PubMed         Abstract available

  19. ASAI S, Kobayashi M, Fukuda S, Kimura K, et al
    Significance of atypical nodules upgraded to category 3 in Prostate Imaging Reporting and Data System version 2.1 for prostate cancer diagnosis.
    Int J Urol. 2024 Feb 12. doi: 10.1111/iju.15421.

    J Magn Reson Imaging

  20. RUAN M, Liu Y, Yao K, Wang K, et al
    Development and Validation of Interpretable Machine Learning Models for Clinically Significant Prostate Cancer Diagnosis in Patients With Lesions of PI-RADS v2.1 Score >/=3.
    J Magn Reson Imaging. 2024 Feb 16. doi: 10.1002/jmri.29275.
    PubMed         Abstract available

  21. ZABIHOLLAHY F, Naim S, Wibulpolprasert P, Reiter RE, et al
    Understanding Spatial Correlation Between Multiparametric MRI Performance and Prostate Cancer.
    J Magn Reson Imaging. 2024 Feb 12. doi: 10.1002/jmri.29287.
    PubMed         Abstract available

    J Natl Cancer Inst

  22. LAO Y, Guan X, Wang J, Bai Y, et al
    RE: Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study.
    J Natl Cancer Inst. 2024 Feb 12:djae032. doi: 10.1093.

    J Nucl Med

  23. MAURER T, Thomas C, Hadaschik B
    The DETECT Trial: Are We on the Verge of Precision Surgery in Primary Prostate Cancer?
    J Nucl Med. 2024 Feb 15:jnumed.123.267187. doi: 10.2967/jnumed.123.267187.

    J Urol

  24. HOUGEN HY, Sjoberg DD, Thomas J, Mahal BA, et al
    Adding a Coefficient for Race to the 4Kscore Improves Calibration for Black Men.
    J Urol. 2024;211:392-399.
    PubMed         Abstract available

    Nat Rev Urol

    ADT intensification to treat biochemically recurrent prostate cancer.
    Nat Rev Urol. 2024 Feb 14. doi: 10.1038/s41585-024-00862.

    PLoS Med

  26. SELLEM L, Srour B, Javaux G, Chazelas E, et al
    Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Sante cohort.
    PLoS Med. 2024;21:e1004338.
    PubMed         Abstract available

    PLoS One

  27. JONEUS P, Johansson P, Langenskiold S
    Novel hormonal therapy versus standard of care-A registry-based comparative effectiveness evaluation for mCRPC-patients.
    PLoS One. 2024;19:e0290833.
    PubMed         Abstract available

  28. NORIEGA LANDA E, Quaye GE, Su X, Badmos S, et al
    Urinary fatty acid biomarkers for prostate cancer detection.
    PLoS One. 2024;19:e0297615.
    PubMed         Abstract available

    Ther Adv Urol

  29. PORCARO AB, Bianchi A, Panunzio A, Gallina S, et al
    The impact of prognostic group classification on prostate cancer progression in intermediate-risk patients according to the European Association of Urology system: results in 479 patients treated with robot-assisted radical prostatectomy at a single t
    Ther Adv Urol. 2024;16:17562872241229260.
    PubMed         Abstract available


  30. HUNG M, Hu JC
    Author Response: Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
    Urology. 2024 Feb 7:S0090-4295(24)00003-7. doi: 10.1016/j.urology.2024.

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.